CTXR Chart Looks Nice + Upcoming Catalyst

NASDAQ:CTXR   Citius Pharmaceuticals, Inc
Analyzing volume using 1hr candles. Take Aways:

1) Consolidating b/t 1.86 to 1.97 -> Needs to break over 2.02 for uptrend confirmation per fib levels
2) Price targets are 2.22 & 2. 40 -> take 50% profit at 2.22 and let rest ride
2) Set SL @ 1.86 for a tight SL, @ 1.58 for loose, and @ 1.35 if you're portfolio can handle the choppiness we're in
3) Mino-lok goes for FDA approval late April. Nearest competition $CRMD failed approval roughly a month ago and dropped 60% on the news so please do not go full port on this

This is not financial advice and should only be used for entertainment purposes. Do your own due diligence.